42 related articles for article (PubMed ID: 38635786)
21. Oncogenic Mutations of MYD88 and CD79B in Diffuse Large B-Cell Lymphoma and Implications for Clinical Practice.
Visco C; Tanasi I; Quaglia FM; Ferrarini I; Fraenza C; Krampera M
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33050534
[TBL] [Abstract][Full Text] [Related]
22. The pathobiology of primary testicular diffuse large B-cell lymphoma: Implications for novel therapies.
Twa DDW; Mottok A; Savage KJ; Steidl C
Blood Rev; 2018 May; 32(3):249-255. PubMed ID: 29289361
[TBL] [Abstract][Full Text] [Related]
23. Non-Hodgkin's lymphoma: the old and the new.
Cabanillas F
Clin Lymphoma Myeloma Leuk; 2011 Jun; 11 Suppl 1():S87-90. PubMed ID: 22035756
[TBL] [Abstract][Full Text] [Related]
24. Primary Central Nervous System Lymphomas: A Diagnostic Overview of Key Histomorphologic, Immunophenotypic, and Genetic Features.
Lauw MIS; Lucas CG; Ohgami RS; Wen KW
Diagnostics (Basel); 2020 Dec; 10(12):. PubMed ID: 33322508
[TBL] [Abstract][Full Text] [Related]
25. [Analysis of genomic copy number alterations of malignant lymphomas and its application for diagnosis].
Tagawa H
Gan To Kagaku Ryoho; 2007 Jul; 34(7):975-82. PubMed ID: 17637530
[TBL] [Abstract][Full Text] [Related]
26. Aggressive B cell lymphomas in the 2017 revised WHO classification of tumors of hematopoietic and lymphoid tissues.
Grimm KE; O'Malley DP
Ann Diagn Pathol; 2019 Feb; 38():6-10. PubMed ID: 30380402
[TBL] [Abstract][Full Text] [Related]
27. Diffuse large B-cell lymphoma.
Li S; Young KH; Medeiros LJ
Pathology; 2018 Jan; 50(1):74-87. PubMed ID: 29167021
[TBL] [Abstract][Full Text] [Related]
28. Large B-Cell Lymphomas in the 5th Edition of the WHO-Classification of Haematolymphoid Neoplasms-Updated Classification and New Concepts.
Kurz KS; Ott M; Kalmbach S; Steinlein S; Kalla C; Horn H; Ott G; Staiger AM
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190213
[TBL] [Abstract][Full Text] [Related]
29. Molecular Subgroups of Diffuse Large B Cell Lymphoma: Biology and Implications for Clinical Practice.
Weber T; Schmitz R
Curr Oncol Rep; 2022 Jan; 24(1):13-21. PubMed ID: 35060000
[TBL] [Abstract][Full Text] [Related]
30. The histological and biological spectrum of diffuse large B-cell lymphoma in the World Health Organization classification.
Menon MP; Pittaluga S; Jaffe ES
Cancer J; 2012; 18(5):411-20. PubMed ID: 23006945
[TBL] [Abstract][Full Text] [Related]
31. ABC, GCB, and Double-Hit Diffuse Large B-Cell Lymphoma: Does Subtype Make a Difference in Therapy Selection?
Nowakowski GS; Czuczman MS
Am Soc Clin Oncol Educ Book; 2015; ():e449-57. PubMed ID: 25993209
[TBL] [Abstract][Full Text] [Related]
32. Primary Large B-Cell Lymphoma of Immune-Privileged Sites of the Cerebellum: A Case Series and Review of the Literature.
Pancetti S; Rahal D; Fernades B; Galli C; Uccella S; Terracciano LM; Pessina F; Bello L; Bonometti A
Life (Basel); 2023 Jan; 13(1):. PubMed ID: 36676150
[TBL] [Abstract][Full Text] [Related]
33. Primary Diffuse Large B-Cell Lymphoma of the Urinary Bladder: Update on a Rare Disease and Potential Diagnostic Pitfalls.
Zanelli M; Sanguedolce F; Zizzo M; Palicelli A; Pellegrini D; Farinacci S; Soriano A; Froio E; Cormio L; Carrieri G; Cavazza A; Merli F; Pileri SA; Ascani S
Curr Oncol; 2022 Feb; 29(2):956-968. PubMed ID: 35200580
[TBL] [Abstract][Full Text] [Related]
34. Primary Mediastinal Nodal and Extranodal Non-Hodgkin Lymphomas: Current Concepts, Historical Evolution, and Useful Diagnostic Approach: Part 1.
Piña-Oviedo S; Moran CA
Adv Anat Pathol; 2019 Nov; 26(6):346-370. PubMed ID: 31567132
[TBL] [Abstract][Full Text] [Related]
35. Heterogeneity among diffuse large B-cell lymphoma: new entities in WHO classification, a first step in personalized therapy.
Rotaru I; Tănase AD; Nacea JG; Pătraşcu Ş; Olteanu OA; Pătraşcu AM
Rom J Morphol Embryol; 2019; 60(1):41-48. PubMed ID: 31263826
[TBL] [Abstract][Full Text] [Related]
36. Genomic profiling using array comparative genomic hybridization define distinct subtypes of diffuse large B-cell lymphoma: a review of the literature.
Tirado CA; Chen W; García R; Kohlman KA; Rao N
J Hematol Oncol; 2012 Sep; 5():54. PubMed ID: 22967872
[TBL] [Abstract][Full Text] [Related]
37. B-cell receptor signaling in diffuse large B-cell lymphoma.
Young RM; Shaffer AL; Phelan JD; Staudt LM
Semin Hematol; 2015 Apr; 52(2):77-85. PubMed ID: 25805587
[TBL] [Abstract][Full Text] [Related]
38. Primary Large B-cell Lymphomas of Immune-Privileged Sites.
Roschewski M; Phelan JD; Jaffe ES
Blood; 2024 Apr; ():. PubMed ID: 38635786
[TBL] [Abstract][Full Text] [Related]
39. MYD88
Chen R; Zhou D; Wang L; Zhu L; Ye X
Ther Adv Hematol; 2022; 13():20406207211072839. PubMed ID: 35126963
[TBL] [Abstract][Full Text] [Related]
40. Lymphomas arising in immune-privileged sites: insights into biology, diagnosis, and pathogenesis.
King RL; Goodlad JR; Calaminici M; Dotlic S; Montes-Moreno S; Oschlies I; Ponzoni M; Traverse-Glehen A; Ott G; Ferry JA
Virchows Arch; 2020 May; 476(5):647-665. PubMed ID: 31863183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]